Skip to main content
. 2020 Dec 31;8(12):e21965. doi: 10.2196/21965

Table 1.

Demographic and clinical characteristics of the Intermountain Healthcare patients with asthma between 2005 and 2016.

Characteristics Data instances related to no asthma hospital visit in the subsequent year (n=303,976), n (%) Data instances related to asthma hospital visits in the subsequent year (n=11,332), n (%) Data instances (n=315,308), n (%)
Gender

Female 181,928 (59.85) 6163 (54.39) 188,091 (59.65)

Male 122,048 (40.15) 5169 (45.61) 127,217 (40.35)
Age (years)

≥65 46,260 (15.22) 621 (5.48) 46,881 (14.87)

18 to 65 172,436 (56.73) 5003 (44.15) 177,439 (56.27)

6 to <18 50,572 (16.64) 2590 (22.86) 53,162 (16.86)

<6 34,708 (11.42) 3118 (27.52) 37,826 (12.00)
Ethnicity

Non-Hispanic 244,442 (80.41) 8157 (71.98) 252,599 (80.11)

Hispanic 27,014 (8.89) 2279 (20.11) 29,293 (9.29)

Unknown or not reported 32,520 (10.70) 896 (7.91) 33,416 (10.60)
Race

White 273,206 (89.88) 9420 (83.13) 282,626 (89.63)

Native Hawaiian or other Pacific Islander 3877 (1.28) 411 (3.63) 4288 (1.36)

Black or African American 5291 (1.74) 460 (4.06) 5751 (1.82)

Asian 2120 (0.70) 77 (0.68) 2197 (0.70)

American Indian or Alaska Native 2295 (0.76) 214 (1.89) 2509 (0.80)

Unknown or not reported 17,187 (5.65) 750 (6.62) 17,937 (5.69)
Duration of asthma (years)

>3 76,810 (25.27) 3666 (32.35) 80,476 (25.52)

≤3 227,166 (74.73) 7666 (67.65) 234,832 (74.48)
Insurance

Self-paid or charity 26,611 (8.75) 1902 (16.78) 28,513 (9.04)

Public 76,916 (25.30) 3238 (28.57) 80,154 (25.42)

Private 200,449 (65.94) 6192 (54.64) 206,641 (65.54)
Smoking status

Never smoker or unknown 251,501 (82.74) 8952 (79.00) 260,453 (82.60)

Former smoker 18,735 (6.16) 569 (5.02) 19,304 (6.12)

Current smoker 33,740 (11.10) 1811 (15.98) 35,551 (11.28)
Comorbidity

Sleep apnea 20,421 (6.72) 471 (4.16) 20,892 (6.63)

Sinusitis 14,164 (4.66) 592 (5.22) 14,756 (4.68)

Premature birth 5102 (1.68) 440 (3.88) 5542 (1.76)

Obesity 35,215 (11.58) 1076 (9.50) 36,291 (11.51)

Gastroesophageal reflux 54,887 (18.06) 1309 (11.55) 56,196 (17.82)

Eczema 4484 (1.48) 443 (3.91) 4927 (1.56)

Cystic fibrosis 447 (0.15) 11 (0.10) 458 (0.15)

Chronic obstructive pulmonary disease 12,496 (4.11) 391 (3.45) 12,887 (4.09)

Bronchopulmonary dysplasia 394 (0.13) 35 (0.31) 429 (0.14)

Anxiety or depression 55,245 (18.17) 1716 (15.14) 56,961 (18.07)

Allergic rhinitis 4534 (1.49) 181 (1.60) 4715 (1.50)
Asthma medication prescription

Systemic corticosteroid 129,318 (42.54) 7324 (64.63) 136,642 (43.34)

Short-acting, inhaled beta-2 agonist 121,983 (40.13) 7545 (66.58) 129,528 (41.08)

Mast cell stabilizer 114 (0.04) 7 (0.06) 121 (0.04)

Long-acting beta-2 agonist 1744 (0.57) 69 (0.61) 1813 (0.58)

Leukotriene modifier 33,187 (10.92) 2320 (20.47) 35,507 (11.26)

Inhaled corticosteroid/long-acting beta-2 agonist combination 42,796 (14.08) 2196 (19.38) 44,992 (14.27)

Inhaled corticosteroid 73,566 (24.20) 4539 (40.05) 78,105 (24.77)